These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 31718595)

  • 21. Inhibition of enhancer of zeste homolog 2 (EZH2) expression is associated with decreased tumor cell proliferation, migration, and invasion in endometrial cancer cell lines.
    Eskander RN; Ji T; Huynh B; Wardeh R; Randall LM; Hoang B
    Int J Gynecol Cancer; 2013 Jul; 23(6):997-1005. PubMed ID: 23792601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-26a suppresses the malignant biological behaviors of papillary thyroid carcinoma by targeting ROCK1 and regulating PI3K/AKT signaling pathway.
    Wu YC; Li SY; Jia YF
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8940-8949. PubMed ID: 31696481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Bioinformatic analysis of CCND2 expression in papillary thyroid carcinoma and its impact on immune infiltration].
    Wang Q; Song B; Hao S; Xiao Z; Jin L; Zheng T; Chai F
    Nan Fang Yi Ke Da Xue Xue Bao; 2024 May; 44(5):981-988. PubMed ID: 38862457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Semaphorin 3D inhibits proliferation and migration of papillary thyroid carcinoma by regulating MAPK/ERK signaling pathway.
    Hai R; You Q; Wu F; Qiu G; Yang Q; Shu L; Xie L; Zhou X
    Mol Biol Rep; 2022 May; 49(5):3793-3802. PubMed ID: 35190928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-30d inhibits the migration and invasion of human esophageal squamous cell carcinoma cells via the post‑transcriptional regulation of enhancer of zeste homolog 2.
    Xie R; Wu SN; Gao CC; Yang XZ; Wang HG; Zhang JL; Yan W; Ma TH
    Oncol Rep; 2017 Mar; 37(3):1682-1690. PubMed ID: 28184915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of long noncoding RNA NONHSAT037832 in papillary thyroid carcinoma and its clinical significance.
    Lan X; Sun W; Zhang P; He L; Dong W; Wang Z; Liu S; Zhang H
    Tumour Biol; 2016 May; 37(5):6117-23. PubMed ID: 26611646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway.
    Hong S; Yu S; Li J; Yin Y; Liu Y; Zhang Q; Guan H; Li Y; Xiao H
    Thyroid; 2016 Dec; 26(12):1733-1743. PubMed ID: 27717302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-101 Targets CXCL12-Mediated Akt and Snail Signaling Pathways to Inhibit Cellular Proliferation and Invasion in Papillary Thyroid Carcinoma.
    Chen F; Yang D; Ru Y; Cao S; Gao A
    Oncol Res; 2019 Jun; 27(6):691-701. PubMed ID: 30832753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-31 inhibits papillary thyroid carcinoma cell biological progression by directly targeting SOX11 and regulating epithelial-to-mesenchymal transition, ERK and Akt signaling pathways.
    Wang Y; Liu BG; Zhou CX
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5863-5873. PubMed ID: 31298337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth-associated protein 43 promotes thyroid cancer cell lines progression via epithelial-mesenchymal transition.
    Zheng C; Quan RD; Wu CY; Hu J; Lin BY; Dong XB; Xia EJ; Bhandari A; Zhang XH; Wang OC
    J Cell Mol Med; 2019 Dec; 23(12):7974-7984. PubMed ID: 31568662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IL13RA2 Is Differentially Regulated in Papillary Thyroid Carcinoma vs Follicular Thyroid Carcinoma.
    Chong ST; Tan KM; Kok CYL; Guan SP; Lai SH; Lim C; Hu J; Sturgis C; Eng C; Lam PYP; Ngeow J
    J Clin Endocrinol Metab; 2019 Nov; 104(11):5573-5584. PubMed ID: 31290966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel lncRNA n384546 promotes thyroid papillary cancer progression and metastasis by acting as a competing endogenous RNA of miR-145-5p to regulate AKT3.
    Feng J; Zhou Q; Yi H; Ma S; Li D; Xu Y; Wang J; Yin S
    Cell Death Dis; 2019 Jun; 10(6):433. PubMed ID: 31160577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The lncRNA UNC5B-AS1 promotes proliferation, migration, and invasion in papillary thyroid cancer cell lines.
    Wang Y; Bhandari A; Niu J; Yang F; Xia E; Yao Z; Jin Y; Zheng Z; Lv S; Wang O
    Hum Cell; 2019 Jul; 32(3):334-342. PubMed ID: 30805847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LHPP inhibits cell growth and migration and triggers autophagy in papillary thyroid cancer by regulating the AKT/AMPK/mTOR signaling pathway.
    Sun W; Qian K; Guo K; Chen L; Xiang J; Li D; Wu Y; Ji Q; Sun T; Wang Z
    Acta Biochim Biophys Sin (Shanghai); 2020 Apr; 52(4):382-389. PubMed ID: 32227107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. microRNA-124-3p inhibits tumourigenesis by targeting mitogen-activated protein kinase 4 in papillary thyroid carcinoma.
    Sun Y; Zhang L; Zhang S
    Cell Biochem Funct; 2020 Dec; 38(8):1017-1024. PubMed ID: 32495394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiR-296-5p suppresses papillary thyroid carcinoma cell growth via targeting PLK1.
    Zhou SL; Tang QL; Zhou SX; Ren RZ
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2084-2091. PubMed ID: 30915753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long noncoding RNA PVT1 modulates thyroid cancer cell proliferation by recruiting EZH2 and regulating thyroid-stimulating hormone receptor (TSHR).
    Zhou Q; Chen J; Feng J; Wang J
    Tumour Biol; 2016 Mar; 37(3):3105-13. PubMed ID: 26427660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FOXE1 inhibits cell proliferation, migration and invasion of papillary thyroid cancer by regulating PDGFA.
    Ding Z; Ke R; Zhang Y; Fan Y; Fan J
    Mol Cell Endocrinol; 2019 Aug; 493():110420. PubMed ID: 31129275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of long non-coding RNA LINC00982 suppresses cell proliferation and tumor growth of papillary thyroid carcinoma through PI3K-ATK signaling pathway.
    Xu D; Yu J; Zhuang S; Zhang S; Hong Z; Yuan C
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31262968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-96-5p promotes the proliferation, invasion and metastasis of papillary thyroid carcinoma through down-regulating CCDC67.
    Liu ZM; Wu ZY; Li WH; Wang LQ; Wan JN; Zhong Y
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3421-3430. PubMed ID: 31081096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.